Literature DB >> 1527638

Low density lipoprotein receptor activity is modulated by soybean globulins in cell culture.

M R Lovati1, C Manzoni, A Corsini, A Granata, R Frattini, R Fumagalli, C R Sirtori.   

Abstract

The effects of major storage globulins from soybean on cholesterol homeostasis were investigated in vitro and in vivo systems. The low density lipoprotein (LDL) uptake and degradation was studied both in human skin fibroblasts (HSF) and in a human hepatoma cell line (Hep G2). In Hep G2 cells a dose-dependent increase of both uptake and degradation of 125I-LDL was induced by the 7S globulin, whereas the 11S globulin exerted a lesser effect that was not dose-related. In HSF cells the 11S globulin increased the uptake of 125I-LDL to a greater extent than did 7S globulin; in this cell line, LDL degradation was not stimulated by either of the globulins. Rats fed a casein-cholesterol diet were treated daily with the 11S or 7S globulins for 2 wk. The administration of soybean globulins significantly reduced cholesterolemia (-35 and -34% with 7S and 11S globulins, respectively, vs. controls). Liver membrane preparations from the casein-cholesterol-fed rats showed a nonsignificant increase in the maximal binding of labeled cholesterol-rich lipoprotein fraction (beta-VLDL) to high affinity receptors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1527638     DOI: 10.1093/jn/122.10.1971

Source DB:  PubMed          Journal:  J Nutr        ISSN: 0022-3166            Impact factor:   4.798


  9 in total

Review 1.  Risks and benefits of soy phytoestrogens in cardiovascular diseases, cancer, climacteric symptoms and osteoporosis.

Authors:  C R Sirtori
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

2.  Postprandial lipemia detects the effect of soy protein on cardiovascular disease risk compared with the fasting lipid profile.

Authors:  Antonio S Santo; Ariana M Santo; Richard W Browne; Harold Burton; John J Leddy; Steven M Horvath; Peter J Horvath
Journal:  Lipids       Date:  2010-10-28       Impact factor: 1.880

3.  Replacement of dietary soy protein isolate with concentrates of soy 7S or 11S globulin has minimal or no effects on plasma lipoprotein profiles and biomarkers of coronary risk in monkeys.

Authors:  Michael R Adams; Mary S Anthony; Haiying Chen; Thomas B Clarkson
Journal:  Atherosclerosis       Date:  2007-03-09       Impact factor: 5.162

Review 4.  Soy proteins and cardiovascular disease.

Authors:  C R Sirtori; M R Lovati
Journal:  Curr Atheroscler Rep       Date:  2001-01       Impact factor: 5.113

5.  Soybean glycinin improves HDL-C and suppresses the effects of rosuvastatin on hypercholesterolemic rats.

Authors:  Priscila G Fassini; Roberto W Noda; Ederlan S Ferreira; Maraiza A Silva; Valdir A Neves; Aureluce Demonte
Journal:  Lipids Health Dis       Date:  2011-09-21       Impact factor: 3.876

6.  β-conglycinin combined with fenofibrate or rosuvastatin have exerted distinct hypocholesterolemic effects in rats.

Authors:  Ederlan S Ferreira; Maraiza A Silva; Aureluce Demonte; Valdir A Neves
Journal:  Lipids Health Dis       Date:  2012-01-13       Impact factor: 3.876

7.  Hypocholesterolaemic effect of rat-administered oral doses of the isolated 7S globulins from cowpeas and adzuki beans.

Authors:  Ederlan S Ferreira; Ana Lucia S Amaral; Aureluce Demonte; Cleslei F Zanelli; Jessica Capraro; Marcello Duranti; Valdir A Neves
Journal:  J Nutr Sci       Date:  2015-02-16

8.  Interactions of β-Conglycinin (7S) with Different Phenolic Acids-Impact on Structural Characteristics and Proteolytic Degradation of Proteins.

Authors:  Jing Gan; Hao Chen; Jiyuan Liu; Yongquan Wang; Satoru Nirasawa; Yongqiang Cheng
Journal:  Int J Mol Sci       Date:  2016-10-02       Impact factor: 5.923

9.  Impact of Soy β-Conglycinin Peptides on PCSK9 Protein Expression in HepG2 Cells.

Authors:  Chiara Macchi; Maria Francesca Greco; Nicola Ferri; Paolo Magni; Anna Arnoldi; Alberto Corsini; Cesare R Sirtori; Massimiliano Ruscica; Carmen Lammi
Journal:  Nutrients       Date:  2021-12-31       Impact factor: 5.717

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.